Vi-CELL BLU 2.0 Viability Analyzer Software

Beckman Coulter Life Sciences, a Danaher company, has launched its Vi-CELL BLU 2.0 Viability Analyzer Software — a major upgrade that enables laboratories to modernise cell viability workflows while maintaining data continuity, compliance and operational confidence. The software supports laboratories in solving complex cell analysis challenges and accelerating the transition from research to biomanufacturing.

Built on the Vi-CELL BLU instrument, the software delivers enhanced data comparability, integrity and uptime, enabling R&D and manufacturing teams to modernise workflows without disrupting established processes. By offering improved cell-counting algorithms and configurable analysis settings designed to align results with legacy instruments, supported by validated software documentation and application guidance, the software helps labs avoid the complexity of an equipment transition.

Additional enhancements include role-based access controls, electronic signatures, audit trails and traceability features to support regulated workflows, streamline integration into GMP environments, and ensure consistency across projects, users and sites.